Literature DB >> 11019719

Pulmonary pathology of acute respiratory distress syndrome.

J F Tomashefski1.   

Abstract

Lung morphology in ARDS reflects the rapid evolution from interstitial and alveolar edema to end-stage fibrosis consequent to injury of the alveolocapillary unit. This morphologic progression, termed diffuse alveolar damage, has been subdivided into sequentially occurring exudative, proliferative, and fibrotic phases. Pulmonary lesions correlate with the phase of alveolar damage rather than its specific cause. The pathologic features are consistent with the effects of a host of injurious stimuli and the complex interaction of inflammatory mediators on alveolar epithelial and capillary endothelial cells. Although ARDS frequently culminates in "interstitial" fibrosis, the organization of intraluminal exudate dominates the histologic picture in the proliferative phase and establishes the framework for subsequent fibrous remodeling of the lung. Involvement of the pulmonary vasculature is an important aspect of ARDS, from the initial phase of edema to the terminal stage of intractable pulmonary hypertension. Vascular lesions include thrombotic, fibroproliferative, and obliterative changes that, like the parenchymal lesions, correlate with the temporal phase of DAD. Although ARDS is characterized by extensive bilateral lung involvement, alveolar damage can also affect the lung in a localized fashion. RAD is associated with the same clinical risk factors as DAD, suggesting that there is a spectrum in the extent of lung involvement and disease severity in patients at risk for ARDS. The factors that govern which patients will develop the fulminant syndrome are poorly understood. It must be re-emphasized that the lung is stereotyped in its response to injury and, consequently, descriptive, or even quantitative, studies of lung morphology can only provide clues regarding the initiating factors and pathogenetic mechanisms of ARDS. Progress in understanding the pathogenesis of ARDS and development of rational approaches to therapy will ultimately depend on careful clinical and experimental studies and the application of immunohistochemical and molecular biology techniques to unravel basic mechanisms of cellular injury and response.

Entities:  

Mesh:

Year:  2000        PMID: 11019719     DOI: 10.1016/s0272-5231(05)70158-1

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  127 in total

Review 1.  Disorders of lung matrix remodeling.

Authors:  Harold A Chapman
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

2.  Perivascular fluid cuffs decrease lung compliance by increasing tissue resistance.

Authors:  Kevin Lowe; Diego F Alvarez; Judy A King; Troy Stevens
Journal:  Crit Care Med       Date:  2010-06       Impact factor: 7.598

Review 3.  Lung Repair and Regeneration in ARDS: Role of PECAM1 and Wnt Signaling.

Authors:  Jesús Villar; Haibo Zhang; Arthur S Slutsky
Journal:  Chest       Date:  2018-10-28       Impact factor: 9.410

Review 4.  Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management.

Authors:  Michael A Matthay; Guy A Zimmerman
Journal:  Am J Respir Cell Mol Biol       Date:  2005-10       Impact factor: 6.914

5.  Recombinant human activated protein C in experimental models of acute lung injury: the timing is critical!

Authors:  Corinna Velik-Salchner; Volker Wenzel; Dirk M Maybauer; Marc O Maybauer
Journal:  Intensive Care Med       Date:  2007-08-02       Impact factor: 17.440

6.  Ventilator-induced lung injury: another sign of aging?

Authors:  Joan R Badia; Niall D Ferguson
Journal:  Intensive Care Med       Date:  2008-01-05       Impact factor: 17.440

Review 7.  Amicus or adversary: platelets in lung biology, acute injury, and inflammation.

Authors:  Fernando A Bozza; Amrapali M Shah; Andrew S Weyrich; Guy A Zimmerman
Journal:  Am J Respir Cell Mol Biol       Date:  2008-08-21       Impact factor: 6.914

8.  Chronic Pancreatitis Associated Acute Respiratory Failure.

Authors:  Murli Manohar; Alok K Verma; Sathisha Upparahalli Venkateshaiah; Nathan L Sanders; Anil Mishra
Journal:  MOJ Immunol       Date:  2017-02-08

Review 9.  Amicus or Adversary Revisited: Platelets in Acute Lung Injury and Acute Respiratory Distress Syndrome.

Authors:  Elizabeth A Middleton; Matthew T Rondina; Hansjorg Schwertz; Guy A Zimmerman
Journal:  Am J Respir Cell Mol Biol       Date:  2018-07       Impact factor: 6.914

10.  Randomized clinical trial of activated protein C for the treatment of acute lung injury.

Authors:  Kathleen D Liu; Joseph Levitt; Hanjing Zhuo; Richard H Kallet; Sandra Brady; Jay Steingrub; Mark Tidswell; Mark D Siegel; Graciela Soto; Michael W Peterson; Mark S Chesnutt; Charles Phillips; Ann Weinacker; B Taylor Thompson; Mark D Eisner; Michael A Matthay
Journal:  Am J Respir Crit Care Med       Date:  2008-06-19       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.